Diagnosis and treatment of tuberculosis in adults with HIV.

Medicine (Baltimore)

Department of Neurology, Changzhi Medical College, Changzhi, Shanxi Province, China.

Published: September 2022

Mycobacterium tuberculosis, the causative agent of tuberculosis (TB), continues to pose a major public health problem and is the leading cause of mortality in people infected with human immunodeficiency virus (HIV). HIV infection greatly increases the risk of developing TB even before CD4+ T-cell counts decrease. Co-infection provides reciprocal advantages to both pathogens and leads to acceleration of both diseases. In HIV-coinfected persons, the diagnosis and treatment of tuberculosis are particularly challenging. Intensifying integration of HIV and tuberculosis control programmes has an impact on reducing diagnostic delays, increasing early case detection, providing prompt treatment onset, and ultimately reducing transmission. In this Review, we describe our current understanding of how these two pathogens interact with each other, new sensitive rapid assays for TB, several new prevention methods, new drugs and regimens.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439776PMC
http://dx.doi.org/10.1097/MD.0000000000030405DOI Listing

Publication Analysis

Top Keywords

diagnosis treatment
8
treatment tuberculosis
8
tuberculosis
5
tuberculosis adults
4
hiv
4
adults hiv
4
hiv mycobacterium
4
mycobacterium tuberculosis
4
tuberculosis causative
4
causative agent
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!